related documents
- Adverse impact of bleeding in patients with acute coronary syndromes Conference Paper
- Bleeding complications predict major cardiovascular outcomes in non ST-elevation acute coronary syndromes: Results from the OASIS-5 trial Conference Paper
- Candesartan improves outcome in patients with low ejection fraction heart failure, irrespective of background dose of ACE inhibitor: An analysis of the CHARM-added trial Conference Paper
- Fondaparinux is associated with substantially less major bleeding and vascular access site complications compared with enoxaparin in patients with acute coronary syndrome undergoing percutaneous coronary intervention: Insights from the OASIS 5 trial Conference Paper
- Fondaparinux versus enoxaparin in patients with acute coronary syndromes without ST-segment elevation: Impact of risk according to the GRACE score Conference Paper
- Increasing occurrence of multivessel intervention and multiple stent placement from 1999 to 2004. The Global Registry of Acute Coronary Events Conference Paper
- Left ventricular dysfunction and mortality in patients with Eisenmenger syndrome Conference Paper
- Left ventricular myocardial performance index is abnormal in patients with repaired tetralogy of Fallot Conference Paper
- Neither Ramipril nor Vitamin E reduce the incidence of atrial fibrillation. Results of the HOPE study Conference Paper
- Presence and type of provocable non pulmonary triggers for atrial fibrillation: Influence of gender and arrhythmia presentation Conference Paper
- Should warfarin be monitored by anticoagulation clinics or by physician practices? Conference Paper
- The OPTIMIZE trial: A randomized cross-over trial of dobutamine echocardiography, with and without Definity (TM) evaluating the effect of contrast on the accuracy of diagnosing coronary artery disease Conference Paper
- The efficacy and safety of fondaparinux versus enoxaparin in non-ST elevation ACS: Impact of renal dysfunction (OASIS 5) Conference Paper
- The oldest old patients have a lower chance for receiving guidelines recommended atrial fibrillation therapy. The experience of the Euro Heart Survey on atrial fibrillation Conference Paper
- Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: A meta-analysis of the randomized trials Conference Paper